The store will not work correctly when cookies are disabled.
2-(3,5-diphenyl-4-(trifluoromethyl)-1H-pyrazol-1-yl)thiazole-4-carboxylic acid
ID: ALA3092150
PubChem CID: 68329608
Max Phase: Preclinical
Molecular Formula: C20H12F3N3O2S
Molecular Weight: 415.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)c1csc(-n2nc(-c3ccccc3)c(C(F)(F)F)c2-c2ccccc2)n1
Standard InChI: InChI=1S/C20H12F3N3O2S/c21-20(22,23)15-16(12-7-3-1-4-8-12)25-26(17(15)13-9-5-2-6-10-13)19-24-14(11-29-19)18(27)28/h1-11H,(H,27,28)
Standard InChI Key: ZCBFSYOZVSEIJA-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
7.9027 -5.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9016 -6.8107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6163 -7.2236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3328 -6.8101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3300 -5.9797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6145 -5.5705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0424 -5.5619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7974 -5.8946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3471 -5.2795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9320 -4.5665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1256 -4.7412 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.2625 -3.8131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0688 -3.6384 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.1519 -2.8177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3969 -2.4849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8474 -3.1002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1654 -5.3636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5030 -6.1176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3230 -6.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8063 -5.5312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4637 -4.7760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6448 -4.6962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2222 -1.6787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8331 -1.1242 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4366 -1.4268 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9720 -6.7009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7576 -6.9529 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.3609 -7.2553 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.1833 -7.4958 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 7 2 0
5 7 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 2 0
10 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
9 17 1 0
15 23 1 0
23 24 1 0
23 25 2 0
8 26 1 0
26 27 1 0
26 28 1 0
26 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 415.40 | Molecular Weight (Monoisotopic): 415.0602 | AlogP: 5.38 | #Rotatable Bonds: 4 |
Polar Surface Area: 68.01 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.17 | CX Basic pKa: 0.45 | CX LogP: 5.92 | CX LogD: 2.47 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.49 | Np Likeness Score: -1.16 |
References
1. Atobe M, Naganuma K, Kawanishi M, Morimoto A, Kasahara K, Ohashi S, Suzuki H, Hayashi T, Miyoshi S.. (2013) SAR-based optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as highly potent EP1 receptor antagonists., 23 (24): [PMID:24252546] [10.1016/j.bmcl.2013.10.065] |